Terms: = Gastric cancer AND SDHB, PGL4, 6390, ENSG00000117118, SDH1, SDHIP, SDH, IP AND Staging
7 results:
1. Intraperitoneal Administration of Paclitaxel Combined with S-1 Plus Oxaliplatin as Induction Therapy for Patients with Advanced gastric cancer with Peritoneal Metastases.
Saito S; Yamaguchi H; Ohzawa H; Miyato H; Kanamaru R; Kurashina K; Hosoya Y; Lefor AK; Sata N; Kitayama J
Ann Surg Oncol; 2021 Jul; 28(7):3863-3870. PubMed ID: 33270170
[TBL] [Abstract] [Full Text] [Related]
2. The Prognostic Effect of Metastatic Lymph Node Ratio in Operated gastric cancer Patients.
Tokgoz S; Bugdayci Basal F
J Coll Physicians Surg Pak; 2020 Oct; 30(10):1035-1040. PubMed ID: 33143823
[TBL] [Abstract] [Full Text] [Related]
3. Ratios of miRNAs in Peritoneal Exosomes are Useful Biomarkers to Predict Tumor Response to Intraperitoneal Chemotherapy in Patients with Peritoneal Metastases from gastric cancer.
Ohzawa H; Kimura Y; Saito A; Yamaguchi H; Miyato H; Sakuma Y; Horie H; Hosoya Y; Lefor AK; Sata N; Kitayama J
Ann Surg Oncol; 2020 Dec; 27(13):5057-5064. PubMed ID: 32804324
[TBL] [Abstract] [Full Text] [Related]
4. The predictive factors of gastric cancer recurrence after the completion of adjuvant chemotherapy in advanced gastric cancer.
Kim YJ; Chung WC; Youn GJ; Jun KH; Chin HM
Rev Esp Enferm Dig; 2019 Jul; 111(7):537-542. PubMed ID: 31215209
[TBL] [Abstract] [Full Text] [Related]
5. Intraperitoneal Administration of Paclitaxel Followed by Paclitaxel, Cisplatin, and S-1 Chemotherapy for Cytology-positive gastric cancer: A Feasibility Study.
Shinkai M; Imano M; Chiba Y; Hiraki Y; Kato H; Iwama M; Shiraisi O; Yasuda A; Tsubaki M; Nishida S; Kimura Y; Yasuda T
Anticancer Res; 2018 Oct; 38(10):5969-5974. PubMed ID: 30275227
[TBL] [Abstract] [Full Text] [Related]
6. [Combination Chemotherapy Including Intraperitoneal(IP)Administration of Paclitaxel(PTX)followed by PTX, CDDP and S-1Triplet Chemotherapy for CY1P0 gastric cancer].
Shinkai M; Imano M; Hiraki Y; Kato H; Iwama M; Shiraishi O; Yasuda A; Kimura Y; Imamoto H; Furukawa H; Yasuda T
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1355-1357. PubMed ID: 29394632
[TBL] [Abstract] [Full Text] [Related]
7. Loss of the promyelocytic leukemia protein in gastric cancer: implications for IP-10 expression and tumor-infiltrating lymphocytes.
Kim HJ; Song DE; Lim SY; Lee SH; Kang JL; Lee SJ; Benveniste EN; Choi YH
PLoS One; 2011; 6(10):e26264. PubMed ID: 22022583
[TBL] [Abstract] [Full Text] [Related]
